Actualités et Activités de Clearside Biomedical
Présence
Siège : Etats—Unis
Clearside Biomedical est une société cotée sous le symbole boursier CLSD (US).
Acquisition, funding and merger involving Clearside Biomedical.
- Clearside Biomedical has gone out of its bankruptcy protection (publié le 15 juillet 2026).
Dirigeants
Voir l'organigramme avec ses 17 principaux dirigeants
Biographies les plus recherchées chez Clearside Biomedical
- George Lasezkay, Chief Executive Officer and Director
- Christy Shaffer, Director
- Clay Thorp, Chairman of the Board
Créer une alerte
pour suivre les mouvements de dirigeants chez Clearside Biomedical.
Biotechnologie
Clearside Biomedical a 2 428 concurrents dont Lonza (Suisse), Vertex Pharmaceuticals (Etats—Unis) et Eurofins (Luxembourg).
Actualités en fusion/acquisition en Biotechnologie.
- Eli Lilly has announced the acquisition of AtaiBeckley (publié le 17 juillet 2026).
- GSK a acquis Nuvalent (publié le 17 juillet 2026).
- Clearside Biomedical has gone out of its bankruptcy protection (publié le 15 juillet 2026).
Contacts en Biotechnologie
Actualités
Derniers communiqués de presse par Clearside Biomedical
- Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process | Clearside Biomedical, Inc.- IR Site
- News | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting | Clearside Biomedical, Inc.- IR Site
- News | Clearside Biomedical, Inc.- IR Site
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Clearside Biomedical
- Clearside Biomedical sur Wikipédia, Google News & Yahoo Finance en 1-click
- Clearside Biomedical sur LinkedIn, X (Twitter) & YouTube en 1-click
